These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10364735)

  • 1. Reproterol: beta-2-agonist, theophylline, or both?
    Virchow JC
    Respiration; 1999; 66(3):210-1. PubMed ID: 10364735
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes.
    Eleno N; Gajate E; Macias J; Garay RP
    Pulm Pharmacol Ther; 1999; 12(1):55-60. PubMed ID: 10208836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproterol--A monomolecular combination of orciprenaline and theophylline: novel aspects of its mode of action in asthma.
    Juergens UR; Stöber M; Vetter H
    Respiration; 1999; 66(3):220-4. PubMed ID: 10364737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mononuclear cell membranes: stabilization by reproterol and cromoglycate, destabilization by fenoterol and salbutamol.
    Zimmer G; Bernhörster M; Pilz P; Schuchmann-Fix J; Hüggelmeier R; Blüm N; Libertus H
    Arzneimittelforschung; 2006; 56(2):76-83. PubMed ID: 16572921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of a fixed combination of reproterol hydrochloride and disodium cromoglycate with each agent alone on antigen-induced airway responses in sheep.
    Abraham WM; Sabater JR; Szelenyi S; Bähre M
    Pulm Pharmacol Ther; 1998; 11(4):271-6. PubMed ID: 10101743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by reproterol of cAMP PDE in intact mastocytoma P-815 cells.
    Alvarez-Guerra M; Libertus H; Garay RP
    Pulm Pharmacol Ther; 2004; 17(4):213-8. PubMed ID: 15219266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of reproterol either alone or combined with disodium cromoglycate on airway responsiveness to methacholine.
    Kanniess F; Jörres RA; Magnussen H
    Pulm Pharmacol Ther; 2005; 18(5):315-20. PubMed ID: 15939309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superoxide radical scavenging by phenolic bronchodilators under aprotic and aqueous conditions.
    Zwicker K; Damerau W; Dikalov S; Scholtyssek H; Schimke I; Zimmer G
    Biochem Pharmacol; 1998 Aug; 56(3):301-5. PubMed ID: 9744566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproterol and the muscle of the trachea and bronchi: in vitro and in vivo comparative studies with various drugs used in the treatment of asthma.
    Di Mezza F; Giordano L; Scognamiglio M; Montanaro A; Marmo E
    Respiration; 1981; 42(3):175-83. PubMed ID: 7313343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-agonistic bronchodilators: comparison of dose/response in working rat hearts.
    Zimmer G; Dahinten A; Fitzner A; Halbig S; Noll T; Treusch F; Libertus H
    Chest; 2000 Feb; 117(2):519-29. PubMed ID: 10669699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cromoglycate, reproterol, or both--what's best for exercise-induced asthma?
    Küpper T; Goebbels K; Kennes LN; Netzer NC
    Sleep Breath; 2012 Dec; 16(4):1229-35. PubMed ID: 22198635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation using dynamic ECG of the effects of reproterol (a new beta-2 adrenergic receptor agonist) on the heart conduction system].
    Citone C; Carelli M; Di Marcotullio G; Tubaro M; Milazzotto F
    Clin Ter; 1984 Sep; 110(5):429-36. PubMed ID: 6149836
    [No Abstract]   [Full Text] [Related]  

  • 13. Histamine release from mast cells and monocytes: the effects of azelastine, reproterol and vitamin A-analogues.
    Bolsmann K; Braam U; Eichelberg D; Greven T; Jungbluth C; Schmutzler W; Zwadlo-Klarwasser G
    Inflamm Res; 1996 Mar; 45 Suppl 1():S5-6. PubMed ID: 8696927
    [No Abstract]   [Full Text] [Related]  

  • 14. Excretion study of the beta2-agonist reproterol in human urine.
    Georgakopoulos CG; Tsitsimpikou C; Spyridaki MH
    J Chromatogr B Biomed Sci Appl; 1999 Apr; 726(1-2):141-8. PubMed ID: 10348180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of disodium cromoglycate with beta-2-agonist in therapy of patients with atopic bronchial asthma (preliminary study)].
    Płusa T; Mamełka B; Chciałowski A; Włodarczyk R
    Pneumonol Alergol Pol; 1993; 61(3-4):183-8. PubMed ID: 8364435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of reproterol's effectiveness in preventing exercise-induced bronchospasm in children.
    Verini M; Ansaloni A; Di Vincenzo MG; Napoleone M; Morgese G
    J Int Med Res; 1985; 13(1):19-23. PubMed ID: 2858421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of exercise-induced asthma by a fixed combination of disodium cromoglycate plus reproterol compared with montelukast in young patients.
    Lecheler J; Pfannebecker B; Nguyen DT; Petzold U; Munzel U; Kremer HJ; Maus J
    Arzneimittelforschung; 2008; 58(6):303-9. PubMed ID: 18677973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels, heart rate, and blood pressure after intravenous, oral, and aerosol administration of reproterol in man.
    Hageman RJ; de Zeeuw RA; Greving JE; Krann JJ; Koëter GH
    Biopharm Drug Dispos; 1988; 9(3):301-14. PubMed ID: 3395671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effect of reproterol upon pulmonary, cardiac, vascular and intestinal 3',5'-monophosphate phosphodiesterase nucleoside.
    Marmo E; Di Mezza F; Giordano L; Matera MG; De Carlo R; Ruggiero E
    J Pharm Pharmacol; 1982 May; 34(5):342-3. PubMed ID: 6123580
    [No Abstract]   [Full Text] [Related]  

  • 20. Adenosine monophosphate bronchial provocation and the actions of asthma therapy.
    Lee DK; Gray RD; Lipworth BJ
    Clin Exp Allergy; 2003 Mar; 33(3):287-94. PubMed ID: 12614440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.